Minh Thu le, MD
Allergy & Immunology · Springfield, MONPI 1174559116
Payments from drug & device makers
Across 895 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- CSL Behring$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- GSK$1K
- Sanofi$1K
- Genentech USA, Inc.$909
- plus $6K from 26 others
What the payments were for
- Consulting fees$420%
- Travel & lodging$410%
- Food & beverage$18,40899%
- Education$1081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 190 | $5,182 |
| CSL Behring | 82 | $1,656 |
| Takeda Pharmaceuticals U.S.A., Inc. | 77 | $1,527 |
| GSK | 100 | $1,484 |
| Sanofi | 60 | $1,422 |
| Genentech USA, Inc. | 45 | $909 |
| Amgen(2 entities) | 43 | $844 |
| Pfizer | 56 | $834 |
| Novartis | 35 | $695 |
| Grifols USA, LLC | 40 | $690 |
| Regeneron Healthcare Solutions, Inc. | 24 | $527 |
| Blueprint Medicines Corporation | 15 | $516 |
| Biocryst US Sales Co., LLC | 16 | $494 |
| Pharming Healthcare, Inc. | 19 | $351 |
| Boehringer Ingelheim | 20 | $302 |
| Kaleo, Inc. | 15 | $200 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $165 |
| Alk-abello, Inc | 8 | $162 |
| AbbVie | 7 | $116 |
| Hospira, Inc. | 4 | $73 |
| Lilly USA, LLC | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 5 | $67 |
| Octapharma USA, Inc. | 3 | $57 |
| ADMA Biomanufacturing LLC | 2 | $42 |
| Optinose US, Inc. | 3 | $39 |
| Tersera Therapeutics LLC | 1 | $39 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Merck | 2 | $32 |
| Incyte Corporation | 2 | $28 |
| Biocryst Pharmaceuticals, Inc. | 1 | $17 |
| Organon | 1 | $16 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,599 in reported general payments places this provider in the 75th percentile of 61 allergy & immunology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TakhzyroLanadelumab-Flyo | 35 | $1,817,588 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 20 | $190,890 |
| XolairOmalizumab | 19 | $89,733 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $81,908 |
| Dupixent SyringeDupilumab | 18 | $68,765 |
| NucalaMepolizumab | 11 | $59,360 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 14 | $48,544 |
| Spiriva RespimatTiotropium Bromide | 64 | $47,399 |
| Breo ElliptaFluticasone/Vilanterol | 95 | $44,771 |
| SymbicortBudesonide/Formoterol Fumarate | 65 | $19,750 |
| Epinephrine | 104 | $19,088 |
| DuleraMometasone/Formoterol | 34 | $12,194 |
| Advair HfaFluticasone Propion/Salmeterol | 26 | $11,404 |
| Ipratropium Bromide | 360 | $9,743 |
| Arnuity ElliptaFluticasone Furoate | 14 | $8,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Takhzyro | $1,527 | $1,817,58835 claims |
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta | $1,484 | $194,099218 claims |
| CSL BehringHizentra | $1,656 | $190,89020 claims |
| Grifols USA, LLCGamunex-C | $690 | $48,54414 claims |
| Boehringer IngelheimSpiriva Respimat | $302 | $47,39964 claims |
| AstraZenecaSymbicort | $5,182 | $19,75065 claims |
| Hikma Pharmaceuticals USAEpinephrine | $34 | $19,088104 claims |
| MerckDulera | $32 | $12,19434 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $67 | $2,97011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 61 allergy & immunology providers in Missouri.
Other allergy & immunology in Springfield
- Brett HronekSpringfield$20K
- William MickaSpringfield$15K
- Seth KnightSpringfield$5K
- Gregory LuxSpringfield$4K
- Jeffrey TillinghastSaint Louis$11M
- H James WednerSaint Louis$2.3M
- Peggy KendallSaint Louis$895K
- Barbara JostSaint Louis$470K
- Phillip KorenblatSaint Louis$453K
- Manoj WarrierSaint Louis$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.